Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial

被引：0
|
作者：
Shankar P Nagaraju
Adam Cohn
Ayub Akbari
Janet L Davis
Deborah L Zimmerman
机构：
[1] Kasturba Medical College,Department of Nephrology
[2] Queensway Carleton Hospital,Department of Medicine
[3] Ottawa Hospital Research Institute,Department of Medicine, Division of Nephrology
[4] Department of Medicine,undefined
[5] Division of Nephrology,undefined
来源：
BMC Nephrology | / 14卷
关键词：
Anemia; Iron; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
    Hirai, Keiji
    Kaneko, Shohei
    Minato, Saori
    Yanai, Katsunori
    Hirata, Momoko
    Kitano, Taisuke
    Ito, Kiyonori
    Ueda, Yuichiro
    Ookawara, Susumu
    Morishita, Yoshiyuki
    FRONTIERS IN MEDICINE, 2023, 10
  • [12] IS SERUM ERYTHROPOIETIN CORRELATED WITH IRON METABOLISM AND INFLAMMATION IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS WITH ANEMIA?
    Capusa, Cristina-Stela
    Mehedinti, Ana-Maria
    Stanciu, Ana
    Talimba, Gabriela-Adriana
    Viasu, Liliana
    Mircescu, Gabriel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 335 - 335
  • [13] A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
    Qunibi, Wajeh Y.
    Martinez, Carlos
    Smith, Mark
    Benjamin, Joseph
    Mangione, Antoinette
    Roger, Simon D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (05) : 1599 - 1607
  • [14] Retrospective Assessment of Total Cost of Care in Non-Dialysis Dependent Chronic Kidney Disease Patients Receiving Parenteral Iron Therapy for Iron Deficiency Anemia
    Wang, Kevin
    Kwong, Jackie
    Wang, Peng
    Boccia, Ralph, V
    BLOOD, 2022, 140 : 4998 - 4999
  • [15] The FIND-CKD study-a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
    Macdougall, Iain C.
    Bock, Andreas
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Roubert, Bernard
    Cushway, Timothy
    Roger, Simon D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 843 - 850
  • [16] Enarodustat Treatment for Renal Anemia in Patients With Non-dialysis Chronic Kidney Disease
    Mima, Akira
    IN VIVO, 2023, 37 (02): : 825 - 829
  • [17] A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial
    Barraclough, Katherine A.
    Brown, Fiona
    Hawley, Carmel M.
    Leary, Diana
    Noble, Euan
    Campbell, Scott B.
    Isbel, Nicole M.
    Mudge, David W.
    van Eps, Carolyn L.
    Johnson, David W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (11) : 4146 - 4153
  • [18] Intravenous versus oral iron supplementation in adult patients with iron-deficiency anemia and non-dialysis dependent chronic kidney disease: A meta-analysis of randomized clinical trials
    Alanazi, Mansuor Ahmed
    Alsaiari, Afnan Saleh M.
    Bukhari, Sarah Fahad M.
    Alanazi, Renad Mohammed H.
    Altmimi, Sarah Muqbil B.
    Alenezi, Rahaf Naif A.
    Rfadh, Shahad Ali M.
    Albalawi, Abdulaziz Ahmed M.
    Almehmadi, Alaa Sulaiman M.
    Albalawi, Shoroug Daher M.
    Alatawi, Wejdan Lafi S.
    MEDICAL SCIENCE, 2023, 27 (131)
  • [19] Prevalence of iron deficiency in patients with non-dialysis chronic kidney disease: The CARENFER national, multicentre, observational study
    Choukroun, Gabriel
    Kazes, Isabelle
    Dantal, Jacques
    Vabret, Elsa
    Couzi, Lionel
    Le Meur, Yannick
    Trochu, Jean-Noel
    Cacoub, Patrice
    Les, Pour
    NEPHROLOGIE & THERAPEUTIQUE, 2022, 18 (03): : 195 - 201
  • [20] Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease
    Coyne, Daniel W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (15) : 2563 - 2568
12345